In modern neuroscience, Alzheimer’s disease is considered one of the greatest challenges, as it causes memory decline, cognitive impairment, and severely affects patients’ quality of life. In addition to environmental factors and aging, genetics plays a crucial role in determining the risk of developing Alzheimer’s. Therefore, research on genes associated with Alzheimer’s risk has become a key direction, helping to explain the mechanisms of the disease and opening up prospects for prevention and personalized treatment.
Among the genes studied, APOE (Apolipoprotein E) is the most prominent. The APOE ε4 variant is regarded as the strongest genetic risk factor for late-onset Alzheimer’s. Individuals carrying one or two copies of this variant have a significantly higher risk of developing the disease compared to those without ε4. In addition, the genes APP, PSEN1, and PSEN2 are linked to early-onset Alzheimer’s, which is rare but strongly hereditary. Mutations in these genes lead to abnormal accumulation of amyloid-beta in the brain, forming plaques that drive neurodegeneration. Furthermore, genes such as BDNF, SIRT1, SIRT3, and FOXO3 have been shown to play roles in protecting neurons, combating oxidative stress, and regulating cellular aging, thereby influencing Alzheimer’s risk.
The mechanisms of these genes are diverse. Some increase the production or reduce the breakdown of amyloid-beta, leading to plaque formation in the brain. Others affect the phosphorylation of tau protein, disrupting neuronal structure. Additionally, genes that regulate inflammatory responses and antioxidant capacity determine the extent of neuronal damage over time.
The applications of genetic research in Alzheimer’s are highly significant. Genetic testing can aid in early diagnosis and risk prediction, especially for individuals with a family history of the disease. Genetic profiles also form the basis of personalized medicine, allowing tailored nutrition, exercise, and treatment plans to reduce risk. Beyond that, this research opens the possibility of developing gene therapies and targeted drugs that directly intervene in related genes or proteins to prevent or slow disease progression.
In conclusion, research on genes associated with Alzheimer’s risk shows that the disease is not only the result of aging and environmental factors but is also strongly influenced by genetics. Understanding the role of risk genes brings medicine closer to the goals of early diagnosis, prevention, and personalized treatment, offering new hope in the fight against the world’s most common neurodegenerative disease.
